This process maximizes the destruction of the tumour while minimising harm to healthy cells.

Malignancy fighting technology uses UV light to strike tumours Scientists in Newcastle University are suffering from a cancers fighting technology which uses UV light to activate antibodies which very specifically assault tumours . Therapeutic antibodies possess long been recognised as having excellent potential but getting them to efficiently focus on tumour cells has became very difficult. Now, Professor Colin Self and Dr Stephen Thompson from Newcastle University have developed an operation to cloak antibodies which can then become activated by UV-A light and so can be targeted to a specific area of the body just by shining a probe at the relevant component.